ABCC7 p.Asn900Asp
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 11443282
[PubMed]
Hammerle MM et al: "A novel CFTR disease-associated mutation causes addition of an extra N-linked oligosaccharide."
No.
Sentence
Comment
23
Tel.: 480-301-6206; Fax: 480-301-7017; E-mail: riordan@mayo.edu N900D, T908N or T910N to produce a CFTR with different numbers or no consensus site for glycosylation on extracytoplasmic loop 4.
X
ABCC7 p.Asn900Asp 11443282:23:65
status: NEW
PMID: 18682497
[PubMed]
Chang XB et al: "Role of N-linked oligosaccharides in the biosynthetic processing of the cystic fibrosis membrane conductance regulator."
No.
Sentence
Comment
20
Mutation of native N-linked glycosylation sites (N894D/N900D) and treatment of cells with tunicamycin resulted in expression of unglycosylated CFTR (Fig. 2A).
X
ABCC7 p.Asn900Asp 18682497:20:55
status: NEW25 Inhibition of interactions with ER lectin chaperones does not affect localization of wild-type or ΔF508 CFTR To analyze whether the N-linked oligosaccharides are involved in retention of ΔF508 CFTR at the ER, we expressed ΔF508 with mutations at both N-glycosylation sites (ΔF508 N894D/N900D) (Fig. 3A).
X
ABCC7 p.Asn900Asp 18682497:25:310
status: NEW26 Similar to non-glycosylated wild-type CFTR, ΔF508 N894D/N900D did not interact with calnexin (Fig. 3B).
X
ABCC7 p.Asn900Asp 18682497:26:62
status: NEW28 At physiological temperature (37°C), ΔF508 localized only to the ER regardless of whether or not it was glycosylated (ΔF508 or ΔF508 N894D/N900D), as observed by immunolocalization of permeabilized cells (Fig. 3C).
X
ABCC7 p.Asn900Asp 18682497:28:162
status: NEW29 Staining of the surface CFTR of intact cells with an antibody recognizing an external epitope confirmed that unglycosylated ΔF508 N894D/N900D was not present at the plasma membrane (Fig. 3D).
X
ABCC7 p.Asn900Asp 18682497:29:142
status: NEW31 When cells were incubated at 27°C, both glycosylated ΔF508 and unglycosylated ΔF508 N894D/N900D could be detected at the cell surface (Fig. 3D).
X
ABCC7 p.Asn900Asp 18682497:31:107
status: NEW34 Cells expressing unglycosylated CFTR N894D/N900D showed a robust chloride efflux response to cAMP-elevating stimuli, whereas ΔF508 N894D/N900D did not display any activity, reflecting the absence of the channel protein at the plasma membrane.
X
ABCC7 p.Asn900Asp 18682497:34:43
status: NEWX
ABCC7 p.Asn900Asp 18682497:34:143
status: NEW36 At 37°C, the wild-type protein was observed primarily in its native location in the apical membrane regardless of its glycosylation state, whereas neither glycosylated ΔF508 nor unglycosylated ΔF508 N894D/N900D CFTR was able to reach the apical membrane and was instead localized intracellulary (Fig. 3F).
X
ABCC7 p.Asn900Asp 18682497:36:222
status: NEW56 However, the other single-site variant, N900D, generated two strong bands, one with a similar mobility to that of N894D, probably representing the presence of the other single chain, and another more rapidly migrating band, most likely representative of a core rather than complex oligosaccharide chain at this site.
X
ABCC7 p.Asn900Asp 18682497:56:40
status: NEW57 The identity of the core-glycosylated forms of N894D and N900D was confirmed by digestion with endoglycosidase H, which selectively deglycosylates unprocessed core-glycosylated proteins and thus converted CFTR to a band with the same mobility as the N894D/N900D double mutant (Fig. 5B).
X
ABCC7 p.Asn900Asp 18682497:57:57
status: NEWX
ABCC7 p.Asn900Asp 18682497:57:256
status: NEW59 However, it appears that the nascent chain with only the N894 site available (N900D), progresses from the core to complex glycosylated state inefficiently.
X
ABCC7 p.Asn900Asp 18682497:59:78
status: NEW62 The oligosaccharide at the N900 site was efficiently attached (N894D Journal of Cell Science 121 (17) in Fig. 5A) and was relatively refractory to removal by the PNGase (Fig. 5C, panel N894D), whereas that at the other site was rapidly removed to yield the unglycosylated species (Fig. 5C, compare panel N900D with N894D/N900D).
X
ABCC7 p.Asn900Asp 18682497:62:304
status: NEWX
ABCC7 p.Asn900Asp 18682497:62:321
status: NEW67 Although unglycosylated N894D/N900D can mature conformationally and reach the cell surface where it functions (Figs 2 and 3), it clearly turns over much more rapidly than the wild-type protein (Fig. 6A).
X
ABCC7 p.Asn900Asp 18682497:67:30
status: NEW69 As had been suggested by the western blots (Fig. 5A), the N900D species matured much less effectively than the wild- Fig. 2.
X
ABCC7 p.Asn900Asp 18682497:69:58
status: NEW71 (A) Western blot of CFTR and unglycosylated CFTR created either by mutation of the glycosylation sites (N894D/N900D) or by expressing CFTR in tunicamycin-treated cells (+ Tunicamycin).
X
ABCC7 p.Asn900Asp 18682497:71:110
status: NEW72 CFTR and CFTR N894D/N900D variants were stably (left panel) or transiently (right panel) expressed in BHK-21 cells.
X
ABCC7 p.Asn900Asp 18682497:72:20
status: NEW75 (B) CFTR N894D/N900D does not interact with calnexin.
X
ABCC7 p.Asn900Asp 18682497:75:15
status: NEW80 Single-channel measurements were performed using membrane vesicles prepared from stably transfected BHK-CFTR, BHK- N894D/N900D cells or from cells transiently transfected with CFTR that were treated with tunicamycin.
X
ABCC7 p.Asn900Asp 18682497:80:121
status: NEW89 Again, in the BFA-treated cells, the N900D species was distinctly different from the others, turning over much more rapidly (Fig. 6B,C).
X
ABCC7 p.Asn900Asp 18682497:89:37
status: NEW90 Thus, N900D CFTR modified with an N-linked oligosaccharide chain only at the N894 site is Fig. 3.
X
ABCC7 p.Asn900Asp 18682497:90:6
status: NEW91 ΔF508 N894D/N900D cannot escape ER quality control.
X
ABCC7 p.Asn900Asp 18682497:91:18
status: NEW92 (A) Western blot of CFTR, CFTR N894D/N900D, ΔF508 and ΔF508 N894D/N900D expressed in BHK-21 cells.
X
ABCC7 p.Asn900Asp 18682497:92:37
status: NEWX
ABCC7 p.Asn900Asp 18682497:92:78
status: NEW94 (B) ΔF508 N894D/N900D does not interact with calnexin.
X
ABCC7 p.Asn900Asp 18682497:94:22
status: NEW95 ΔF508 N894D/N900D was immunoprecipitated by incubation with anti-CFTR antibody 596 crosslinked to Dynabeads.
X
ABCC7 p.Asn900Asp 18682497:95:18
status: NEW110 This was further confirmed by the application of the proteasomal inhibitor ALLN, which significantly stabilized CFTR N900D, but neither CFTR N894D nor the double mutant (supplementary material Fig. S4).
X
ABCC7 p.Asn900Asp 18682497:110:117
status: NEW112 We found that N894D interacted more strongly with calnexin than did N900D (Fig. 7A), but more of the latter was found in association with EDEM (Fig. 7B).
X
ABCC7 p.Asn900Asp 18682497:112:68
status: NEW114 By contrast, the oligosaccharide at position 894, which seems to direct the single mutant primarily into a degradative pathway at the ER, might support EDEM interaction in the N900D mutant, which is similar to that of the wild-type protein, whereas binding to calnexin is reduced.
X
ABCC7 p.Asn900Asp 18682497:114:176
status: NEW181 The CFTR variant with a single oligosaccharide at position 894 (N900D) was much more susceptible to deglycosylation by PNGase, whereas the variant with glycosylation at position 900 (N894D) was surprisingly resistant to this treatment.
X
ABCC7 p.Asn900Asp 18682497:181:64
status: NEW183 This suggests that N900D CFTR, with a glycan at position 894, might be a much better substrate for this pathway than the N894D variant.
X
ABCC7 p.Asn900Asp 18682497:183:19
status: NEW185 With just the oligosaccharide chain at position 900 (N894D), turnover was similar to that of the wild-type protein; however, with an oligosaccharide attached only at position 894 (N900D), CFTR maturation was very inefficient.
X
ABCC7 p.Asn900Asp 18682497:185:180
status: NEW187 The conclusion that N900D CFTR is a better substrate for ERAD than N894D CFTR was further strengthened by the preferential interaction of N900D CFTR with EDEM, which was similar to that of the wild-type protein, but which was reduced in the N894D mutant (Fig. 7), and by the observation Fig. 7.
X
ABCC7 p.Asn900Asp 18682497:187:20
status: NEWX
ABCC7 p.Asn900Asp 18682497:187:138
status: NEW188 Interaction of N894D and N900D single-chain mutants with calnexin and EDEM.
X
ABCC7 p.Asn900Asp 18682497:188:25
status: NEW189 (A) Cell lysates from BHK-21 cells stably expressing CFTR, CFTR N894D, CFTR N900D or CFTR N894D/N900D were subjected to immunoprecipitation by incubation with anti-CFTR antibody 596 crosslinked to Dynabeads (IP: CFTR, as indicated on the left).
X
ABCC7 p.Asn900Asp 18682497:189:76
status: NEWX
ABCC7 p.Asn900Asp 18682497:189:96
status: NEW192 (B) CFTR was immunoprecipitated from cells that were stably expressing CFTR, CFTR N894D, CFTR N900D or CFTR N894D/N900D and that were also transiently expressing HA-tagged EDEM, by incubation with anti-CFTR monoclonal antibody 596 crosslinked to Dynabeads. EDEM was detected by western blotting using monoclonal antibody HA11 and CFTR using antibody 596.
X
ABCC7 p.Asn900Asp 18682497:192:94
status: NEWX
ABCC7 p.Asn900Asp 18682497:192:114
status: NEW202 The carbohydrate at position 900 in CFTR N894D supports the route to maturation and progress to the Golgi, whereas the oligosaccharide at asparagine residue 894 in N900D promotes degradation.
X
ABCC7 p.Asn900Asp 18682497:202:164
status: NEW203 that the proteasomal inhibitor ALNN stabilized N900D CFTR, but not N894D CFTR (supplementary material Fig. S4).
X
ABCC7 p.Asn900Asp 18682497:203:47
status: NEW204 It seems likely that the double mutant behaves in the ER like CFTR N894D rather than like CFTR N900D, because the presence of the oligosaccharide at N894 supports the ERAD pathway, whereas the absence of this oligosaccharide allows the double glycosylation mutant to exit the ER and proceed to the Golgi and plasma membrane.
X
ABCC7 p.Asn900Asp 18682497:204:95
status: NEW207 We cannot rule out the possibility that the lack of glycans might affect the conformation of CFTR and that the N900D mutation is accompanied by a significant degree of misfolding that makes it a better ERAD substrate.
X
ABCC7 p.Asn900Asp 18682497:207:111
status: NEW219 Materials and Methods Mutagenesis and stable expression of CFTR Replacement of asparagine residues N894 and N900 with aspartate residues was achieved by replacing a CFTR HpaI-DraIII cDNA fragment (bp 2463 to 3328) in pNUT CFTR with a counterpart generated by PCR coding for N894D, N900D or N894D/N900D, to produce CFTRs with only one or no glycosylation site (Chang et al., 1994).
X
ABCC7 p.Asn900Asp 18682497:219:281
status: NEWX
ABCC7 p.Asn900Asp 18682497:219:296
status: NEW224 The well-differentiated cultures were then transduced with adenoviral vectors as described previously (Coyne et al., 2000) to express Extope-CFTR and Extope-ΔF508 with intact or mutated glycosylation sites (N894D/N900D).
X
ABCC7 p.Asn900Asp 18682497:224:219
status: NEW
PMID: 19307599
[PubMed]
Glozman R et al: "N-glycans are direct determinants of CFTR folding and stability in secretory and endocytic membrane traffic."
No.
Sentence
Comment
24
Results Cell surface expression of glycosylation-deficient CFTR is severely reduced CFTR glycosylation was abolished by mutagenesis of the two consensus Asn-linked N-glycosylation sites (Kornfeld and Kornfeld, 1985) individually (N894D and N900D) or together (2D-CFTR) in CFTR.
X
ABCC7 p.Asn900Asp 19307599:24:240
status: NEW26 [ID]FIG1[/ID] The endoglycosidase (endo) H and F sensitivity of N894D- and N900D-CFTR verified that both glycan chains underwent complex glycosylation, whereas the 2D-CFTR failed to obtain N-glycans (Fig. 1 B).
X
ABCC7 p.Asn900Asp 19307599:26:75
status: NEW27 Indirect immunostaining of the extracellular 3HA tag in nonpermeabilized cells revealed that N894D-, N900D-, and 2D-CFTR were expressed at the cell surface, as proved by colocalization with Alexa Fluor 594-conjugated wheat germ agglutinine (WGA), a plasma membrane marker (Fig. 1 C).
X
ABCC7 p.Asn900Asp 19307599:27:101
status: NEW28 Quantitative analysis of CFTR cell surface density by anti-HA antibody (Ab) binding to the 3HA tag revealed that the N894D-, N900D-, and 2D-CFTR expression level was decreased by ~37%, ~63%, and ~87%, respectively, relative to wild-type (wt) CFTR, which is in line with the immunostaining results (Fig. 1 D).
X
ABCC7 p.Asn900Asp 19307599:28:125
status: NEW54 The wt CFTR folding efficiency (34.0 ± 5.6%) was reduced to 15.6 ± 0.5% and 13.8 ± 1.2% in N894D- and N900D-CFTR, respectively (Fig. 2 A).
X
ABCC7 p.Asn900Asp 19307599:54:117
status: NEW92 The transport-competent native 2D-CFTR has threefold accelerated (t1/2 = ~4 h), whereas the N894D- and N900D-CFTR have approximately twofold faster metabolic turnover rates than the wt channel (t1/2 = ~12 h; Fig. 4, A and B).
X
ABCC7 p.Asn900Asp 19307599:92:103
status: NEW303 The N894D-/N900D-CFTR (2D-CFTR) was generated using the N894D-CFTR as a template and the N900D mutagenic primers.
X
ABCC7 p.Asn900Asp 19307599:303:11
status: NEWX
ABCC7 p.Asn900Asp 19307599:303:89
status: NEW306 Cell culture and transfection Stably transfected BHK cell lines expressing wt, N894D, N900D, 2D-, 2A-, and 2Q- or ΔF508-CFTR-2D as well as N900D+T908N- and 2D+T908N-CFTR variants were generated as described previously (Du et al., 2005).
X
ABCC7 p.Asn900Asp 19307599:306:86
status: NEW
PMID: 20008117
[PubMed]
Cholon DM et al: "Modulation of endocytic trafficking and apical stability of CFTR in primary human airway epithelial cultures."
No.
Sentence
Comment
268
A: Western blot of lysates of HAE cells adenovirally expressing CFTR N894D N900D, in which asparagine residues N894 and N900 are replaced with aspartate, confirmed lack of glycosylation.
X
ABCC7 p.Asn900Asp 20008117:268:75
status: NEW269 B: primary HAE cultures were adenovirally transduced to express wild-type CFTR and a nonglycosylated variant (N894D N900D) of CFTR.
X
ABCC7 p.Asn900Asp 20008117:269:116
status: NEW272 Time course experiments were performed on 3 different HAE cultures; 1 representative example is shown. D: immunofluorescence labeling of sodium-potassium-chloride cotransporter isoform 1 (NKCC1) confirms that internalized CFTR N894D N900D is transported to basolateral compartments.
X
ABCC7 p.Asn900Asp 20008117:272:233
status: NEW273 HAE cultures were adenovirally transduced to express CFTR N894D N900D.
X
ABCC7 p.Asn900Asp 20008117:273:64
status: NEW266 A: Western blot of lysates of HAE cells adenovirally expressing CFTR N894D N900D, in which asparagine residues N894 and N900 are replaced with aspartate, confirmed lack of glycosylation.
X
ABCC7 p.Asn900Asp 20008117:266:75
status: NEW267 B: primary HAE cultures were adenovirally transduced to express wild-type CFTR and a nonglycosylated variant (N894D N900D) of CFTR.
X
ABCC7 p.Asn900Asp 20008117:267:116
status: NEW270 Time course experiments were performed on 3 different HAE cultures; 1 representative example is shown. D: immunofluorescence labeling of sodium-potassium-chloride cotransporter isoform 1 (NKCC1) confirms that internalized CFTR N894D N900D is transported to basolateral compartments.
X
ABCC7 p.Asn900Asp 20008117:270:233
status: NEW271 HAE cultures were adenovirally transduced to express CFTR N894D N900D.
X
ABCC7 p.Asn900Asp 20008117:271:64
status: NEW
No.
Sentence
Comment
31
Structural destabilization of the Pma1 and Gap1 transmembrane domains in strains defective of sphingoid base synthesis could be mechanistically similar to the farnesol-induced 484 Membranes and organelles Table 1 Peripheral protein QC substrates Membrane protein Mutation/condition Degron PM stability Related disease Reference Mammalian bile salt export pump (BSEP) E297G (Cy) D482G (Cy) 2-3 Ub # progressive familial intrahepatic cholestasis type 2 (PFIC2) [36] CFTR rDF508 (Cy) poly/multimono Ub # cystic fibrosis (CF) [44 ,27 ] D70 (Cy truncation) poly/multimono Ub # [27 ] N894D, N900D (Ex) poly/multimono Ub # [22] Na/H exchanger (NHE6) D255-256 (TM) poly/multimono Ub # Angelman syndrome [35] MLC1 multiple (TM or Cy) ND # megalencephalic leukoencephalopathy with subcortical cysts (MLC) [66] HERG low K+ Ub # type 2 long QT syndrome [37] LDL receptor high salt or low pH (Ex) ND # hypercholesterolemia [16] Dopamine D4.4 receptor M345T (TM) poly/multimono Ub # attention deficit hyperactivity disorder [28 ] Vasopressin V2 receptor W164S (TM) poly/multimono Ub # nephrogenic diabetes insipidus [28 ] alpha-2A adrenergic receptor D79N (TM) ND # cardiovascular diseases [14] N422D (TM) ND # [14] Di3loop (Cy) ND # [69] CD4tl-lm L57C (Cy) poly/multimono Ub # model protein [28 ] H+ /K+ -ATPase b subunit N99Q, N130Q, N161Q, N222Q (Ex) ND # gastric, autoimmune diseases [18] k opioid receptor N25/39Q (Ex) ND # pain control, neuronal phenotypes [19] D opioid receptor N18Q/N33Q (Ex) ND # pain control, neuronal phenotypes [20] GLUT1 N45Y, Q or D (ex) ND # GLUT1 deficiency syndrome [70] EGFR L858R (Cy), exon 19 deletion (Cy) poly/multimono Ub # cancer suspectibility [71] ErbB2 Hsp90 inhibition poly/multimono Ub # breast cancer [72] TGFBR2 Hsp90 inhibition poly/multimono Ub # tumor suspectibility [73] Yeast Pma1 Icb1-100 poly/multimono Ub # NA [29] Pma1-7 poly/multimono Ub # NA [7] Pma1-10 poly/multimono Ub # NA [52] Gap1 absence of sphingolipids poly/multimono Ub # NA [9] Abbreviations: Cy, cytosolic; Ex, extracellular; TM, transmembrane; Ub, ubiquitin; ND, not determined; #, decreasing stability; CFTR, cystic fibrosis transmembrane conductance regulator; HERG, human ether-a` -go-go related gene; LDL, low-density lipoprotein; GLUT, glucose transporter; EGFR, epidermal growth factor receptor; ErbbB2, v-erb-b2 erythroblastic leukemia viral oncogene homolog 2; TGFBR2, transforming growth factor (TGF)- beta type II; Pma1, H(+)-ATPase; Gap1, general amino acid permease.
X
ABCC7 p.Asn900Asp 21571517:31:589
status: NEW
No.
Sentence
Comment
211
Complex N-glycosylation of EL1 only, was confirmed when EL4 glycosylation sites were mutated14 (substitutions N894D/N900D), and of both EL1 and EL4 when sites were present in both loops.
X
ABCC7 p.Asn900Asp 17113596:211:116
status: NEW209 Complex N-glycosylation of EL1 only, was confirmed when EL4 glycosylation sites were mutated14 (substitutions N894D/N900D), and of both EL1 and EL4 when sites were present in both loops.
X
ABCC7 p.Asn900Asp 17113596:209:116
status: NEW
PMID: 7518437
[PubMed]
Chang XB et al: "Mapping of cystic fibrosis transmembrane conductance regulator membrane topology by glycosylation site insertion."
No.
Sentence
Comment
22
A fragment inwild- type pNUT-CFTR (21, 22) was replaced by a PCR fragment (between HpaI site atnucleotide 2463 andDraIII site atnucleotide 3328)coding for the N894D and N900D changes to produce aCFTR with no consensus glycosylation sites on extracytoplasmic loops (designated ELO,Fig.
X
ABCC7 p.Asn900Asp 7518437:22:169
status: NEW